News

Co-Founder and CEO, Andrea Mazzocchi is celebrated as a CEO of the Year 2023 by Utah Business

3.21.23

Known Medicine CTO, Katie-Rose Skelly, shares how we work to remove the guesswork from cancer treatments

2.22.23---This episode features a conversation with Katie-Rose Skelly, co-founder and CTO, and Pete Codella, managing director of business services at the Governor's Office of Economic Opportunity

Known Medicine Recognized by Utah “100 Companies Championing Women” Initiative

1.26.23--100 Companies Championing Women

Business Wire: Known Medicine Announces BioTech Breakthrough Award for “Best Use of Artificial Intelligence in BioTech 2022”

1.19.23---Known Medicine was selected out of a pool of 1,350 nominations worldwide.

Co-Founder and CTO, Katie-Rose Skelly is selected as a Forbes 30 Under 30 in Healthcare

11.29.22

Docs and Drug Discovery

11.1.22---How Known Medicine Partners with Clinicians to Advance Cancer Treatments

Known Medicine is recognized by BioUtah as a visionary Utah company, revolutionizing precision cancer drug development

9.29.22

Learning at Known Medicine

8.15.22---Summer Intern, Cara Guernsey, reflects on her experience in our Biology team at Known Medicine

Known Medicine wins VentureBeat's AI Innovator Award

7.20.22

Known Medicine is highlighted by Utah Business as an emerging healthcare innovations leader.

5.31.22

Patients First

5.24.22---Most drugs in Phase III clinical trials fail because they cannot account for patient-specific responses. Our platform identifies patient responses a priori & leads to clinical success.

How Known Medicine Helped Me Become a Better Marketing Strategist

5.18.22---Supporting students is part of our core values of Audaciousness & Kindness. Our marketing intern, Mel, reflects on her experience with us & the opportunity to improve her marketing skills.

Business Wire: Known Medicine Appoints Kristen Fortney to Advisory Board

4.11.22---BioAge Labs CEO & co-founder brings extensive knowledge and experience in early stage drug discovery strategy.

Altitude Lab Announces First Cohort of Startups, Including Known Medicine, Close Over $50M in Seed Capital

3.30.22

Harnessing the Immune System to Treat Cancer

3.29.22---We are taking the experiment out of the patient and finding new drug therapies for cancer. Learn more about how our immunotherapies run on our novel platform can change the lives of patients

The Right Drug for Every Patient

3.15.22---Our platform can be used to avoid the astronomical costs of failed clinical trials by taking the experiment out of the patient and re-creating drug responses in our lab.

The Female Factor: Known Medicine’s Innovators in Biomedical Science

3.8.22

Business Wire: Known Medicine Partners with Duke University to Predict Lung Cancer Response to Drug Treatments

3.3.22

Known Medicine — 2021 Year in Review

1.27.22---This past year was one of learning, growing, and finding success at Known Medicine.

Known Medicine CEO and co-founder, Dr. Andrea Mazzocchi is recognized by BioUtah as an extraordinary female leader and innovator in Utah's life sciences industry.

9.23.21

Business Wire: Known Medicine Raises $7.2 Million Seed Round to Advance Data First Approach to Organoid Technology

8.25.21

Known Medicine CEO, Dr. Andrea Mazzocchi, discusses the future of lung cancer precision medicine on Lungcast™

7.19.21---Our CEO and co-founder helps define precision lung cancer care.

CEO Andrea Mazzocchi discusses women in innovative sciences with ABC 4 News

6.14.21---IN FOCUS Discussion: Women in innovative science

Known Medicine Shows its BioHive Pride

6.4.21---Known Medicine is creating the world’s largest purpose-built 3D cell culture data set to predict the best drug for every cancer patient and create the best drug for every cancer.

Cancer Precision Medicine — Taking the experiment out of the patient

5.5.21---Precision medicine is the use of a patient’s own tissue, health records, or data to make healthcare related decisions.

Building a Useful Biological Dataset

3.10.21---Our goal at Known Medicine is to predict which treatments every cancer patient will and won’t respond to. In order to succeed we need the right data collected the right way.

Here are the 98 companies from Y Combinator’s Summer 2020 Demo Day 1

8.24.20---Today was part one of Y Combinator’s two-parter Summer 2020 Demo Day, where nearly 100 companies debuted their efforts to the world for the first time.

Y Combinator startup grows mini-tumors to take the guesswork out of personalizing cancer treatments

8.11.20---From targeted drugs to immunotherapies, cancer care has made enormous strides over the years.

Sending the Ladder Down While Still Climbing

8.11.20---Recursion Co-founder and CEO reflects on the successful Altitude Lab incubator and opportunity for new biotech companies to thrive in Salt Lake City.